Trials / Completed
CompletedNCT00398125
Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults
A Phase 2a, Multicenter, Randomized, Parallel, Double-Blind, Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK364735 Monotherapy Versus Placebo Over 10 Days in HIV-1 Infected Adults.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To investigate safety, tolerability and anti-viral activity in Integrase-Naïve HIV-1 infected adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK364735 |
Timeline
- Start date
- 2006-11-01
- Completion
- 2007-04-01
- First posted
- 2006-11-10
- Last updated
- 2012-07-30
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00398125. Inclusion in this directory is not an endorsement.